Literature DB >> 15625129

Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency.

Lesley Gerrard1, Debiao Zhao, A John Clark, Wei Cui.   

Abstract

Human embryonic stem cells (hESCs) are derived from the inner cell mass of preimplantation embryos; they can be cultured indefinitely and differentiated into many cell types in vitro. These cells therefore have the ability to provide insights into human disease and provide a potential unlimited supply of cells for cell-based therapy. Little is known about the factors that are important for maintaining undifferentiated hESCs in vitro, however. As a tool to investigate these factors, transfected hES clonal cell lines were generated; these lines are able to express the enhanced green fluorescent protein (EGFP) reporter gene under control of the OCT4 promoter. OCT4 is an important marker of the undifferentiated state and a central regulator of pluripotency in ES cells. These OCT4-EGFP clonal cell lines exhibit features similar to parental hESCs, are pluripotent, and are able to produce all three embryonic germ layer cells. Expression of OCT4-EGFP is colocalized with endogenous OCT4, as well as the hESC surface antigens SSEA4 and Tra-1-60. In addition, the expression is retained in culture for an extensive period of time. Differentiation of these cells toward the neural lineage and targeted knockdown of endogenous OCT4 expression by RNA interference downregulated the EGFP expression in these cell lines, and this correlates closely with the reduction of endogenous OCT4 expression. Therefore, these cell lines provide an easy and noninvasive method to monitor expression of OCT4 in hESCs, and they will be invaluable for studying not only OCT4 function in hESC self-renewal and differentiation but also the factors required for maintenance of undifferentiated hESCs in culture.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15625129     DOI: 10.1634/stemcells.2004-0102

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  57 in total

1.  Dynamic methylation and expression of Oct4 in early neural stem cells.

Authors:  Shih-Han Lee; Jennie N Jeyapalan; Vanessa Appleby; Dzul Azri Mohamed Noor; Virginie Sottile; Paul J Scotting
Journal:  J Anat       Date:  2010-07-14       Impact factor: 2.610

2.  Generation of human embryonic stem cell reporter lines expressing GFP specifically in neural progenitors.

Authors:  Parinya Noisa; Alai Urrutikoetxea-Uriguen; Meng Li; Wei Cui
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

3.  Permanently blocked stem cells derived from breast cancer cell lines.

Authors:  Gangadharan B Sajithlal; Kristi Rothermund; Fang Zhang; David J Dabbs; Jean J Latimer; Stephen G Grant; Edward V Prochownik
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

4.  Production of stem cells with embryonic characteristics from human umbilical cord blood.

Authors:  C P McGuckin; N Forraz; M-O Baradez; S Navran; J Zhao; R Urban; R Tilton; L Denner
Journal:  Cell Prolif       Date:  2005-08       Impact factor: 6.831

Review 5.  Potential for access to embryonic-like cells from human umbilical cord blood.

Authors:  C P McGuckin; N Forraz
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

6.  Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny.

Authors:  M Howe; J Zhao; Y Bodenburg; C P McGuckin; N Forraz; R G Tilton; R J Urban; L Denner
Journal:  Cell Prolif       Date:  2009-03-25       Impact factor: 6.831

7.  HIF induces human embryonic stem cell markers in cancer cells.

Authors:  Julie Mathieu; Zhan Zhang; Wenyu Zhou; Amy J Wang; John M Heddleston; Claudia M A Pinna; Alexis Hubaud; Bradford Stadler; Michael Choi; Merav Bar; Muneesh Tewari; Alvin Liu; Robert Vessella; Robert Rostomily; Donald Born; Marshall Horwitz; Carol Ware; C Anthony Blau; Michele A Cleary; Jeremy N Rich; Hannele Ruohola-Baker
Journal:  Cancer Res       Date:  2011-06-28       Impact factor: 12.701

8.  Derivation of genetically modified human pluripotent stem cells with integrated transgenes at unique mapped genomic sites.

Authors:  Eirini P Papapetrou; Michel Sadelain
Journal:  Nat Protoc       Date:  2011-08-04       Impact factor: 13.491

9.  Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.

Authors:  Zoe Redshaw; Alastair J Strain
Journal:  J Negat Results Biomed       Date:  2010-03-31

10.  Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors.

Authors:  Tanja Musch; Yuva Oz; Frank Lyko; Achim Breiling
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.